Bristol-Myers Squibb is committed to helping appropriate patients get access to our medications by providing access and reimbursement support services.

This information is intended for U.S. healthcare professionals and/or healthcare professionals involved in healthcare reimbursement.




  • NULOJIX (in combination with basiliximab induction, mycophenolate mofetil [MMF], and corticosteroids) is indicated for prophylaxis of organ rejection in adults receiving a kidney transplant
  • Use NULOJIX only in patients who are Epstein-Barr virus (EBV) seropositive
  • Use of NULOJIX for prophylaxis of organ rejection in transplanted organs other than kidney has not been established

Co Pay and Financial Assistance Icon

Co-Pay and
Financial Assistance

BMS Access Support® can help identify financial assistance programs for eligible patients who have been prescribed NULOJIX and who need help managing the cost of treatment. The appropriate program will depend on the patient's coverage.

Patients With Commercial (Private) Insurance

The BMS Kidney Transplant Co-Pay Assistance Program provides financial help with the out-of-pocket deductibles, co-pay, or co-insurance costs for eligible, commercially insured patients who have been prescribed a BMS kidney transplant medication.


Patients With Insurance Through Federal Healthcare Programs

  • Patients insured through Federal Healthcare Programs are not eligible for co-pay assistance programs sponsored by Bristol-Myers Squibb.
  • BMS Access Support can make a referral to independent charitable foundations offering support for your specific patient. Please contact BMS Access Support at 1-800-861-0048 for details.

Patients Without Prescription Drug Coverage or Who Are Underinsured

  • For patients without prescription drug insurance or for patients who are underinsured, BMS Access Support can make a referral to independent charitable foundations that may be able to help.
  • The Bristol-Myers Squibb Patient Assistance Foundation (BMSPAF), a charitable organization, may also provide medicine, free of charge, to eligible, uninsured patients who have an established financial hardship. For more information and eligibility criteria, visit

The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol-Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.

Support Center icon
8 am to 8 pm ET,
Monday - Friday
Schedule a Call iconSchedule a Call

Schedule a call from a Care Coordinator

Request a Visit icon Request a Visit

Request a visit from a BMS Access & Reimbursement Manager

BMS Logo

©2017 Bristol-Myers Squibb Company. All rights reserved. Access Support and Access Support logo are registered trademarks of Bristol-Myers Squibb Company.

Use of the information on this site is subject to the terms of our Legal Notice and Privacy Statement. The coding, coverage, and payment information contained within this website is current as of 03/17.

721US1605616-01-01 03/17